Asensus Surgical Inc 's ROA from the second quarter of 2024 to the second quarter of 2023 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

What is Asensus Surgical Inc 's ROA in the second quarter of 2024?
Asensus Surgical Inc recorded a cumulative net loss of $-84 million during 12 months ending in the second quarter of 2024, resulting in a negative return on assets (ROA) of -152.27%.

However, within the Healthcare sector 940 other companies had a higher return on assets. While return on assets, the total ranking has deteriorated compared to the first quarter of 2024 from 4818 to 4839.

What is ROA?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Assets ROA▼

None ▼

Return on Assets ROA▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Assets	(Jun 30 2024) II. Quarter	(Mar 31 2024) I. Quarter	(Dec 31 2023) IV. Quarter	(Sep 30 2023) III. Quarter	(Jun 30 2023) II. Quarter
Y / Y Total Assets Change	-50.89 %	-58.13 %	-41.02 %	-45.65 %	-46.81 %
Y / Y Net Income Change	-	-	-	-	-
Net Income (TTM) in million	-84	-79	-78	-79	-80
Return On Assets (TTM)	-152.27 %	-121.09 %	-99.07 %	-86.57 %	-75.03 %
ASXC's Total Ranking	# 4839	# 4818	# 5478	# 4851	# 4865
Total Assets (TTM) in million	38	41	70	71	78
Seq. Total Assets Change	-5.7 %	-41.78 %	-0.89 %	-9.75 %	-19.6 %
Seq. Net Income Change	-	-	-	-	-

ASXC's 5 Years Annual ROA >> Back to ASXC Management Effectiveness >> Compare ASXC ROA to its Competitors

Return On Assets Company Ranking
Within:	No.
Industry	# 215
Sector	# 941
Overall	# 4754

Return On Assets Statistics
High	Average	Low
-20.83 %	-84.72 %	-366.44 %
(Mar 31 2016)		(Dec 31 2012)

Financial Statements
Asensus Surgical Inc 's Assets	$ 38 million	ASXC's Balance sheet
Asensus Surgical Inc 's Income	$ -26 million	Quarterly ASXC's Income Statement
ASXC's Income by Division		See ASXC's Income by Division

Annual Return On Assets	(Dec 31 2023) FY 2023	(Dec 31 2022) FY 2022	(Dec 31 2021) FY 2021	(Dec 31 2020) FY 2020	(Dec 31 2019) FY 2019
Y / Y Total Assets Change	-41.02 %	-36.26 %	138.28 %	4.65 %	-68.75 %
Total Assets in million	70	119	186	78	75
Y / Y Net Income Change	-	-	-	-	-
Net Income in million	-78	-76	-62	-59	-154
Annual Return On Assets	-111.89 %	-63.57 %	-33.5 %	-75.79 %	-206.21 %

ASXC's 5 Years Annual ROA >> Back to ASXC Management Effectiveness >> Compare ASXC ROA to its Competitors

More Return On Assets Ratios
ASXC's' Return on Assets at Yahoo Finance
Medical Equipment & Supplies Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
ASXC's Roa Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for ASXC's Competitors
Subscribers only: Roa for Asensus Surgical Inc 's Suppliers
Subscribers only: Return On Assets for ASXC's Customers

You may also want to know
ASXC's Roi	ASXC's Inventory Turnover Ratio	ASXC's Growth Rates	ASXC's Dividend Comparisons
	ASXC's Profitability Ratios	ASXC's Asset Turnover Ratio	ASXC's Dividend Growth
ASXC's Roe	ASXC's Valuation Ratios	ASXC's Financial Strength Ratios	ASXC's Dividend Payout Ratio

Companies with similar Return On Assets at Jun 30 2024, within Healthcare Sector

ROA

Date modified: 2026-09-26T07:09:41+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.